Sign inJoin waitlistJoin the waitlist

Mandeep Bajaj

Endocrinology, Diabetes & Metabolism · Baylor College of Medicine

Credentials: · · ·

History

Baylor College of Medicine
1998–2000
Montefiore Hospital and Medical Center
1995–1998
Baylor St. Luke's Medical Center
1992–1995
All India Institute of Medical Sciences
1989–1992
All India Institute of Medical
1985–1989

Research

A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes
Diabetes · 2003 · 383 citations
SGLT-2 Inhibition with Dapagliflozin Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Cardiomyopathy in Mice with Type 2 Diabetes.…
Cardiovascular Drugs and Therapy · 2017 · 324 citations
Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients
The Journal of Clinical Endocrinology & Metabolism · 2004 · First of 9 authors · Corresponding · 300 citations

Ralph DeFronzo
19 papers
YB
Yochai Birnbaum
19 papers
SK
Sangeeta Kashyap
11 papers
Kenneth Cusi
10 papers
Susan Samson
5 papers
LC
Lawrence Chan
4 papers
Nuha El Sayed
4 papers
Carol Levy
3 papers
CN
Chiadi Ndumele
3 papers
DS
Donald Simonson
3 papers
EC
Eugenio Cersosimo
3 papers
Fatima Rodriguez
3 papers

Clinical trials

Effect of Dapagliflozin on Inflammation and Endothelial Function
Principal investigator · Terminated · Phase 4
Baylor College of Medicine
2015–2019
Effect of Saxagliptin Treatment on Myocardial Fat Content, and Monocyte Inflammation
Principal investigator · Terminated · Phase 4
Baylor College of Medicine
2012–2017
Effect of Exenatide on Liver and Heart Fat and Inflammation
Principal investigator · Completed · Phase 4
Baylor College of Medicine
2010–2013
Effect Of Exenatide Treatment on Liver Fat Content in Patients With Diabetes
Principal investigator · Completed · Phase 4
Baylor College of Medicine
2007–2009